What does Farmave do?

Farmave is a rental company in Menen. Private Limited, started on 8 July 2021, 1 establishment.

What is the address of Farmave?

The registered office of Farmave is located at Volkslaan 111, 8930 Menen.

Is Farmave still active?

Yes. According to the CBE (31 October 2026) Farmave is active, legal situation “Normale toestand”, started on 8 July 2021.

Is Farmave registered on Peppol?

Yes, Farmave is registered on the Peppol network with ID 0208:0770922148.

What is the enterprise number of Farmave?

The enterprise number of Farmave is BE0770922148.

When was Farmave founded?

Farmave was founded on 8 July 2021.

Who are the directors of Farmave?

According to the 2025 annual accounts, the directors of Farmave are: GEROFARMA BV, VEMAPHAR BV.

Is Farmave a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 July 2021; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Farmave make in 2025?

Farmave recorded a loss after taxes of € 5,604 in financial year 2025.

What is the revenue of Farmave?

As a small company, Farmave is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 61,401.

How many employees does Farmave have?

According to the 2025 annual accounts, Farmave has 0 full-time equivalents (FTE).

Farmave (Private Limited) - Menen - BE0770922148

Dossier Farmave, printed on 31 October 2026 from databakkes.be/en/0770922148/farmave. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 49 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Farmave from Menen, company number BE0770922148, closed financial year 2025 with a result of € -5,604 after tax. For that financial year Farmave recorded a gross margin of € 61,401 and equity of € 64,300. Compared with financial year 2024, the result moved from € -4,764 to € -5,604. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What it is worth Healthy

€ 64,300

▼ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -5,604

▼ 18 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 12,964

▲ 76% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 7,072.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 7,044

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 565,578

▲ 68% vs 2024

€ 87,714 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 7,072

▼ 29% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 46,692 Gross margin 2022: € 46,692 First fiscal year in the series	€ 52,561 Gross margin 2023: € 52,561 ▲ 13% vs 2022 (€ 46,692) Favourable step	€ 65,569 Gross margin 2024: € 65,569 ▲ 25% vs 2023 (€ 52,561) Favourable step	€ 61,401 Gross margin 2025: € 61,401 ▼ 6% vs 2024 (€ 65,569) Unfavourable step	▼ 6%
Profit after taxes	€ 4,911 Profit after taxes 2022: € 4,911 First fiscal year in the series	€ -33,473 Profit after taxes 2023: € -33,473 ▼ € 38,384 vs 2022 (€ 4,911) Unfavourable step	€ -4,764 Profit after taxes 2024: € -4,764 ▲ € 28,709 vs 2023 (€ -33,473) Favourable step	€ -5,604 Profit after taxes 2025: € -5,604 ▼ € 840 vs 2024 (€ -4,764) Unfavourable step	▼ € 840
Equity	€ 208,140 Equity 2022: € 208,140 First fiscal year in the series	€ 74,667 Equity 2023: € 74,667 ▼ 64% vs 2022 (€ 208,140) Unfavourable step	€ 69,903 Equity 2024: € 69,903 ▼ 6% vs 2023 (€ 74,667) Unfavourable step	€ 64,300 Equity 2025: € 64,300 ▼ 8% vs 2024 (€ 69,903) Unfavourable step	▼ 8%
Total debts	€ 258,331 Total debts 2022: € 258,331 First fiscal year in the series	€ 388,444 Total debts 2023: € 388,444 ▲ 50% vs 2022 (€ 258,331) Unfavourable step	€ 347,440 Total debts 2024: € 347,440 ▼ 11% vs 2023 (€ 388,444) Favourable step	€ 572,650 Total debts 2025: € 572,650 ▲ 65% vs 2024 (€ 347,440) Unfavourable step	▲ 65%
Cash	€ 138,445 Cash 2022: € 138,445 First fiscal year in the series	€ 43,497 Cash 2023: € 43,497 ▼ 69% vs 2022 (€ 138,445) Unfavourable step	€ 7,370 Cash 2024: € 7,370 ▼ 83% vs 2023 (€ 43,497) Unfavourable step	€ 12,964 Cash 2025: € 12,964 ▲ 76% vs 2024 (€ 7,370) Favourable step	▲ 76%
Land & buildings	-	€ 211,342 Land & buildings 2023: € 211,342 First fiscal year in the series	€ 204,528 Land & buildings 2024: € 204,528 ▼ 3% vs 2023 (€ 211,342) Unchanged	€ 400,431 Land & buildings 2025: € 400,431 ▲ 96% vs 2024 (€ 204,528) Unchanged	▲ 96%
Retained profit	€ 150,913 Retained profit 2022: € 150,913 First fiscal year in the series	€ 17,440 Retained profit 2023: € 17,440 ▼ 88% vs 2022 (€ 150,913) Unfavourable step	€ 12,676 Retained profit 2024: € 12,676 ▼ 27% vs 2023 (€ 17,440) Unfavourable step	€ 7,072 Retained profit 2025: € 7,072 ▼ 44% vs 2024 (€ 12,676) Unfavourable step	▼ 44%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 100,000 Dividend 2023: € 100,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 100,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 252,833 Bank debt 2022: € 252,833 First fiscal year in the series	€ 385,834 Bank debt 2023: € 385,834 ▲ 53% vs 2022 (€ 252,833) Unfavourable step	€ 337,500 Bank debt 2024: € 337,500 ▼ 13% vs 2023 (€ 385,834) Favourable step	€ 565,578 Bank debt 2025: € 565,578 ▲ 68% vs 2024 (€ 337,500) Unfavourable step	▲ 68%
Balance sheet total	€ 466,471 Balance sheet total 2022: € 466,471 First fiscal year in the series	€ 463,111 Balance sheet total 2023: € 463,111 ▼ 1% vs 2022 (€ 466,471) Unchanged	€ 417,343 Balance sheet total 2024: € 417,343 ▼ 10% vs 2023 (€ 463,111) Unchanged	€ 636,950 Balance sheet total 2025: € 636,950 ▲ 53% vs 2024 (€ 417,343) Unchanged	▲ 53%

Key figures of Farmave, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Farmave?

What happened at Farmave in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 1, 2026 New annual accounts for financial year 2025: loss of € 5,604. Source: NBB ↗
2023 GEROFARMA BV became a director. NBB
Jul 8, 2021 New establishment in Menen. KBO
Jul 8, 2021 Start of the company according to the CBE. KBO
2021 VEMAPHAR BV became a director. NBB

In short

From € 4,911 profit in 2022 to € 5,604 loss in 2025.

Paid € 1,291 in corporate taxes since 2022.

Best year ever: 2022, with € 4,911 profit.

Paid out € 100,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

VEMAPHAR 50%

geroFarma 50%

The stake of VEMAPHAR, geroFarma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Farmave

Behind Farmave are GEROFARMA BV and VEMAPHAR BV. The shares are held by VEMAPHAR (50%) and geroFarma (50%).

Directors

According to the 2025 annual accounts

GEROFARMA BV

Director · represented by Loosveldt Fien

Also active at: SANOPHAR

since 2023

VEMAPHAR BV

Director · represented by Maertens Veronique

Also active at: Apotheek Popelier, SANOPHAR, APOTHEEK MAERTENS

since 2021

Shareholders

VEMAPHAR

50%

geroFarma

50%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Volkslaan 111

8930 Menen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

SANOPHAR same network

€ 352,673 gross margin · 2025

GROEP SANOVE

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0770.922.148

VAT number

BE 0770.922.148

Registered office

Volkslaan 111, 8930 Menen

Names & denominations

Farmave

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

8 July 2021

Peppol

Active · Active since 4 Jun 2025

Contact

056/402039

Activities · NACE

Verhuur en lease van andere machines en werktuigen en andere materiële goederen

Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht

View on CBE Public ↗ Annual accounts (NBB) ↗

Farmave

Warning lights

Financials

What happened to Farmave?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions